Evaluation of a Human Bio-Engineered Skin Equivalent for Drug Permeation Studies
Purpose. To test the barrier function of a bio-engineered human skin (BHS) using three model drugs (caffeine, hydrocortisone, and tamoxifen) in vitro. To investigate the lipid composition and microscopic structure of the BHS.
Methods. The human skin substitute was composed of both epidermal and dermal layers, the latter having a bovine collagen matrix. The permeability of the BHS to three model drugs was compared to that obtained in other percutaneous testing models (human cadaver skin, hairless mouse skin, and EpiDerm™). Lipid analysis of the BHS was performed by high performance thin layered chromatrography. Histological evalulation of the BHS was performed using routine H&E staining.
Results. The BHS mimicked human skin in terms of lipid composition, gross ultrastructure, and the formation of a stratum corneum. However, the permeability of the BHS to caffeine, hydrocortisone, and tamoxifen was 3-4 fold higher than that of human cadaver skin.
Conclusions. In summary, the results indicate that the BHS may be an acceptable in vitro model for drug permeability testing.
- 1.R. L. Bronaugh and H. I. Maibach. In Vitro Percutaneous Absorption: Principles, Fundamentals and Applications, Boca Raton, Fl, CRC Press (1991).Google Scholar
- 2.R. Panchagnula, K. Stemmer, and W. A. Ritschel. Animal models for transdermal drug delivery. Methods Find Exp. Clin. Pharmacol. 19:335–341 (1997).Google Scholar
- 3.M. Ponec, M. Haverkort, Y. L. Soei, J. Kempenaar, and H. Bodde. Use of human keratinocyte and fibroblast cultures for toxicity studies of topically applied compounds. J. Pharm. Sci. 79:312–316 (1990).Google Scholar
- 4.D. A. Godwin, B. B. Michniak, and K. E. Creek. Evaluation of transdermal penetration enhancers using a novel skin alternative. J. Pharm. Sci. 86: 1001–1005 (1997).Google Scholar
- 5.I. V. Yannas, J. F. Burke, M. Warpehoski, P. Stasikelis, E. M. Skrabut, and D. P. Orgill. Design principles and preliminary clincial performance of an artificial skin. In Biomaterials: Interfacial Phenomena and Applications. 1982, pp. 476–481.Google Scholar
- 6.J. F. Morgan and M. L. Yarmush. Bioengineered skin substitutes. Science & Medicine. 6–15 (1997).Google Scholar
- 7.M. Muhart, S. McFalls, R. Kirsner, F. Kerdel, and W. H. Eaglstein. Bioengineered skin [letter]. Lancet. 350:1142 (1997).Google Scholar
- 8.T. J. Phillips. New skin for old: Developments in biological skin substitutes [editorial; comment]. Arch. Dermatol. 134:344–349 (1998).Google Scholar
- 9.J. F. Trent, R. S. Kirsner. Tissue engineered skin: Apligraf, a bilayered living skin equivalent. Int. J. Clin. Pract. 52:408–413 (1998).Google Scholar
- 10.J. G. Rheinwald and H. Green. Serial cultivation of strains of human epidermal keratinocytes. The formation of keratinizing colonies from single cells. Cell 6:331–343 (1975).Google Scholar
- 11.E. Bell, H. P. Ehrlich, D. J. Buttle and T. Nakatsuji. Living tissue formed in vitro and accepted as skin-equivalent tissue of full thickness. Science 211: 1052–1054 (1981).Google Scholar
- 12.M. Rosdy, B. Grisoni, and L. C. Clauss. Proliferation of normal human keratinocytes on silicone substrates. Biomaterials 12:511–517 (1991).Google Scholar
- 13.V. H. Mak, M. B. Cumpstone, A. H. Kennedy, C. S. Harmon, R. H. Guy, and R. O. Potts. Barrier function of human keratinocyte cultures grown at the air-liquid interface. J. Invest. Dermatol. 96:323–327 (1991).Google Scholar
- 14.N. Kim, M. El-Khalili, M. M. Henary, L. Strekowski, and B. B. Michniak. Percutaneous penetration enhancement activity of aromatic S, S-dimethyliminosulfuranes. Int. J. Pharm. 187:219–229 (1999).Google Scholar
- 15.B. B. Michiak, M. R. Player, J. M. Chapman, and J. W. Sowell. In vitro evaluation of a seies of Azone analogs as dermal penetration enhancers: I. Int. J. Pharm. 91:85–93 (1993).Google Scholar
- 16.L. C. Fuhrman, B. B. Michniak, C. R. Behl, and A. W. Malick. Effect of novel penetration enhancers on the transdermal delivery of hydrocortisone: an in vitro species comparison. J. Control. Rel. 45:197–204 (1996).Google Scholar
- 17.I. H. Blank, R. J. Scheuplein, and D. J. MacFarlane. Mechanism of percutaneous absorption. 3. The effect of temperature on the transport of non-electrolytes across the skin. J. Invest. Dermatol. 49:582–589 (1967).Google Scholar
- 18.C. A. Squier, P. Cox, and P. W. Wertz. Lipid content and water permeability of skin and oral mucosa. J. Invest. Dermatol. 96:123–126 (1991).Google Scholar
- 19.D. T. Downing, M. E. Stewart, P. W. Wertz, S. W. Colton, W. Abraham, and J. S. Strauss. Skin lipids: an update. J. Invest. Dermatol. 88:2s–6s (1987).Google Scholar
- 20.P. W. Wertz and D. T. Dowing. Stratum Corneum: Biological and biochemical considerations. In Transdermal Drug Delivery, J. Hadgraft and Richard H. Guy. Eds, Markel Dekker Inc., New York, 1989, pp. 1–22.Google Scholar
- 21.M. Ponec, A. Weerheim, J. Kempenaar, A. M. Mommaas, and D. H. Nugteren. Lipid composition of cultured human keratinocytes in relation to their differentiation. J. Lipid Res. 29:949–961 (1988).Google Scholar
- 22.M. Ponec. Reconstruction of human epidermis on deepidermized dermis: Expression of differentiation-specific protein markers and lipid composition, Toxicol. in Vitro. 5:597–606 (1991a).Google Scholar
- 23.P. W Wertz, and D. T. Downing. Glucosylceramides of pig epidermis: Structure determination. J. Lipid Res. 24:1135–1139 (1983).Google Scholar
- 24.P. W. Wertz and D. T. Downing. Acylglucosylceramides of pig epidermis: structure determination. J. Lipid Res. 24:753–758 (1983).Google Scholar